Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Nature
|
April 21, 2022
Global seasonal forecasts of marine heatwaves
Michael G Jacox, Michael A Alexander, Dillon Amaya, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s
Marie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.
Journal of the American Academy of Dermatology
|
January 24, 2024
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial
Loretta Fiorillo, Emily Becker, Raul de Lucas, et al.
Child Maltreatment
|
December 15, 2023
Clinical Consultation During a Trauma-Focused Cognitive Behavioral Therapy Community-Based Learning Collaborative: Examination of Consultation Content, Consultative Strategies, and Provider Engagement
Grace S Woodard, Ashley Smith Cheng, Dominique A Phillips, et al.
Therapeutic Advances in Gastroenterology
|
December 6, 2021
α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis
Michaela Melde, Tanja M Müller, Ines Schneider, et al.
BMC Gastroenterology
|
April 16, 2020
Baseline levels of dynamic CD4<sup>+</sup> T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study
Clarissa Allner, Michaela Melde, Emily Becker, et al.
Behaviour Research and Therapy
|
September 3, 2017
The relationship between consumer, clinician, and organizational characteristics and use of evidence-based and non-evidence-based therapy strategies in a public mental health system
Rinad Beidas, Laura Skriner, Danielle Adams, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
October 22, 2022
Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease
Ines Schneider, Clarissa Allner, Laura Mühl, et al.
Clinical and Translational Medicine
|
April 8, 2023
Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing
Katrin Sommer, Karin Heidbreder, Lucas Kreiss, et al.
Frontiers in Pharmacology
|
February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Charlotte Lichnog, Sha Klabunde, Emily Becker, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Nature
|
April 21, 2022
Global seasonal forecasts of marine heatwaves
Michael G Jacox, Michael A Alexander, Dillon Amaya, et al.
Inflammatory Bowel Diseases
|
May 23, 2018
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s
Marie-Theres Binder, Emily Becker, Maximilian Wiendl, et al.
Journal of the American Academy of Dermatology
|
January 24, 2024
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial
Loretta Fiorillo, Emily Becker, Raul de Lucas, et al.
Child Maltreatment
|
December 15, 2023
Clinical Consultation During a Trauma-Focused Cognitive Behavioral Therapy Community-Based Learning Collaborative: Examination of Consultation Content, Consultative Strategies, and Provider Engagement
Grace S Woodard, Ashley Smith Cheng, Dominique A Phillips, et al.
Therapeutic Advances in Gastroenterology
|
December 6, 2021
α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis
Michaela Melde, Tanja M Müller, Ines Schneider, et al.
BMC Gastroenterology
|
April 16, 2020
Baseline levels of dynamic CD4<sup>+</sup> T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study
Clarissa Allner, Michaela Melde, Emily Becker, et al.
Behaviour Research and Therapy
|
September 3, 2017
The relationship between consumer, clinician, and organizational characteristics and use of evidence-based and non-evidence-based therapy strategies in a public mental health system
Rinad Beidas, Laura Skriner, Danielle Adams, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
October 22, 2022
Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease
Ines Schneider, Clarissa Allner, Laura Mühl, et al.
Clinical and Translational Medicine
|
April 8, 2023
Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing
Katrin Sommer, Karin Heidbreder, Lucas Kreiss, et al.
Frontiers in Pharmacology
|
February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Charlotte Lichnog, Sha Klabunde, Emily Becker, et al.
Page
of 5